Novavax Reports First-Quarter 2014 Financial Results

[GlobeNewswire] – GAITHERSBURG, Md. — Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today reported … more

View todays social media effects on NVAX

View the latest stocks trending across Twitter. Click to view dashboard

See who Novavax is hiring next, click here to view